Home > Balance Sheet > VENUS REMEDIES

VENUS REMEDIES
Contingent Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹31 Cr₹30 Cr₹40 Cr₹11 Cr₹0.16 Cr

What is the latest Contingent Liabilities ratio of VENUS REMEDIES ?

The latest Contingent Liabilities ratio of VENUS REMEDIES is ₹31 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹31 Cr
Mar2024₹30 Cr
Mar2023₹40 Cr
Mar2022₹11 Cr
Mar2021₹0.16 Cr

How is Contingent Liabilities of VENUS REMEDIES Trending?

Years Contingent Liabilities % Change
Mar2025 ₹31 Cr
0.51
Mar2024 ₹30 Cr
-23.13
Mar2023 ₹40 Cr
272.42
Mar2022 ₹11 Cr
6,423.93
Mar2021 ₹0.16 Cr -

Compare Contingent Liabilities of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹605.5 Cr -2.4% -0.3% 36.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,329.0 Cr 0.9% 3.7% -13.5% Stock Analytics
DIVIS LABORATORIES ₹173,991.0 Cr 7.4% 9% 8.2% Stock Analytics
CIPLA ₹126,326.0 Cr 3.3% 0.2% -7.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,126.0 Cr -0.7% -1.7% -0.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,324.0 Cr 1% -3.2% -5.2% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-2.4%

-0.3%

36.1%

SENSEX

0.7%

1.1%

0.9%


You may also like the below Video Courses